CA
NZ
UK
AU
IND
US
Matinas BioPharma Holdings, Inc. (NYSE American:MTNB) has become one of the most heavily traded US tickers by share count. The working premise that this is a Nasdaq stock is wrong: the Form 10-Q cover page for the quarter ended identifies NYSE American. The premise …
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) is a British Virgin Islands-incorporated maker of traditional Chinese medicine pieces, based in Taizhou, Jiangsu province. Its Class A ordinary shares (not units, warrants or preferred stock) trade on the Nasdaq Capital Market under SXTC. As a foreign private …
Entera Bio Ltd. (NASDAQ:ENTX) is a clinical-stage biopharmaceutical company incorporated in Israel whose ordinary shares trade on the Nasdaq Capital Market as ENTX. It reports as a US domestic filer: EDGAR records under CIK 0001638097 show Forms 10-K, 10-Q and 8-K, not the 20-F …
Gossamer Bio, Inc. (NASDAQ:GOSS) is a San Diego-based, Delaware-incorporated clinical-stage biopharmaceutical company whose common stock trades on Nasdaq as GOSS. Its prospects rest almost entirely on seralutinib, an inhaled inhibitor of PDGFR, CSF1R and c-KIT for pulmonary arterial hypertension (PAH). Within five months it …
Centene Corporation (NYSE:CNC) shares jumped in pre-market trading on Tuesday after the company delivered a sharp second-quarter earnings beat, with adjusted earnings per share of $2.51 crushing analyst estimates of roughly $1.08 and revenue of $53.58 billion topping consensus of about $47.6 billion.
IQVIA Holdings (NYSE:IQV) shares surged in pre-market trading on Tuesday after the company reported second-quarter results that topped Wall Street estimates on both the top and bottom lines. Adjusted earnings per share of $3.15 beat a consensus estimate of $3.03, while revenue of $4.37 …
Kiniksa Pharmaceuticals (NASDAQ:KNSA) shares surged in pre-market trading on Tuesday after the company reported second-quarter results that beat Wall Street estimates on both earnings and revenue, with adjusted earnings per share of $0.30 topping a consensus estimate of $0.27 to $0.28 and revenue of …
Neumora Therapeutics (NASDAQ:NMRA) shares ticked down modestly in pre-market trading on Tuesday, pulling back slightly after a sharp 11.41 percent surge in the prior session that followed favorable repeat toxicology results for NMRA-215, the company's brain-penetrant oral NLRP3 inhibitor being developed for obesity and …
OPKO Health (NASDAQ:OPK) shares climbed in pre-market trading on Tuesday after the company reported a narrower-than-expected second-quarter loss following its earnings release after Monday's close. The company posted a net loss of $0.01 per share, versus consensus estimates of a $0.08 loss, on revenue …
Scribe Therapeutics (NASDAQ:SCTX) shares ticked higher in pre-market trading on Tuesday, recovering slightly after falling 13.77 percent in Monday's session, just days after the company's initial public offering on the Nasdaq Global Market. The stock priced at $15.00 per share on July 24, with …
Please wait processing your request...